Skip to main content
. Author manuscript; available in PMC: 2018 Jul 1.
Published in final edited form as: Ultrasound Med Biol. 2017 Apr 28;43(7):1378–1390. doi: 10.1016/j.ultrasmedbio.2017.01.028

Table 3.

Blood Contents Change. “*” indicates significant difference.

Thrombolysis Treatments (N = 14) Free-flow Treatments (N = 8) Two Weeks of Recovery (N = 4)
Baseline1 Post Baseline2 Post Baseline3 Two weeks later
Free Hgb (mg/dL) 3.8 ± 3.4 63.2± 21.6* 56.7 ± 25.1 78.1 ± 13.9 2.3 ± 0.8 2.1 ± 1.0
LDH (U/L) 404.4 ± 104.3 524.6 ± 130.1* 554.1 ± 132.0 608.4 ± 164.5 355.0 ± 78.0 334.5 ± 67.0
K (mmol/L) 4.1 ± 0.2 4.9 ± 0.5* 4.7 ± 0.4 4.9 ± 0.5 4.0 ± 0.3 3.6 ± 0.2
Serum Hematocrit (%PCV) 26.6 ± 2.5 27.1 ± 3.2 27.3 ± 3.9 27.3 ± 3.1 28.3 ± 1.0 25.3 ± 3.6
pH 7.3 ± 0.1 7.3 ± 0.1 7.4 ± 0.1 7.4 ± 0.1 7.3 ± 0.1 7.4 ± 0.03
SBP (mmHg) 81.4 ± 11.2 86.6 ± 10.8 84.5 ± 9.2 86.0 ± 11.3 NA NA
HR (BPM) 79.8 ± 11.2 79.9 ± 12.5 76.6 ± 13.6 78.4 ± 14.5 NA NA
1

The baselines are the measurements before any treatments and calculated using all 14 samples.

2

The baselines are the measurements after the thrombolysis treatments and before the free-flow treatments and calculated only using the corresponding 8 samples.

3

The baselines are the measurements before any treatments and calculated only using the corresponding 4 samples.